A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function
Objectives: To study the prevalence of fungal species in cystic fibrosis (CF) patients over a 16 years period. To examine the impact of Candida albicans (C. albicans), Candida dubliniensis (C. dubliniensis) and Aspergillus fumigatus (A. fumigatus) on lung function. Methods: Observational single-cent...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971220303702 |
id |
doaj-c2912a51795f40e5979ba92dc2fa708e |
---|---|
record_format |
Article |
spelling |
doaj-c2912a51795f40e5979ba92dc2fa708e2020-11-25T02:54:40ZengElsevierInternational Journal of Infectious Diseases1201-97122020-07-0196663670A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung functionMahasin Al Shakirchi0Lena Klingspor1Peter Bergman2Lena Hjelte3Isabelle de Monestrol4Stockholm Cystic Fibrosis Centre, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden; Corresponding author. Stockholm CF center K56-58, Barnmottagning, Albatross, Karolinska Universitetssjukhuset Huddinge, 141 86 Stockholm, Sweden.Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, SwedenDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, The Immunodeficiency Unit, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, SwedenStockholm Cystic Fibrosis Centre, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, SwedenStockholm Cystic Fibrosis Centre, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, SwedenObjectives: To study the prevalence of fungal species in cystic fibrosis (CF) patients over a 16 years period. To examine the impact of Candida albicans (C. albicans), Candida dubliniensis (C. dubliniensis) and Aspergillus fumigatus (A. fumigatus) on lung function. Methods: Observational single-center cohort study (2000–2015) including 133 CF patients (ages 6–66 years). Linear mixed models with autoregressive covariance matrix were used. Results: The most common fungus was C. albicans (prevalence 62%) followed by A. fumigatus (22%) and C. dubliniensis (11%). In the initial year of detection, there was no impact of C. albicans, C. dubliniensis or A. fumigatus on lung function. However, one and two years after detection of C. dubliniensis a reduction in percent predicted forced expiratory volume in the first second (ppFEV1) was observed of 3.8% (p = 0.022) and 4.1% (p = 0.017), respectively, compared with CF patients without these findings. Furthermore, patients with positive cultures for any of these fungal species for three consecutive years exhibited a decline in lung function: C. dubliniensis, 7.6% reduction in ppFEV1 (p = 0.001); A. fumigatus, 4.9% (p = 0.007); C. albicans, 2.6% (p = 0.014). The results were adjusted for age, CFTR genotype, chronic and intermittent P. aeruginosa colonization, and numbers of intravenous antibiotic treatments per year. Persistence of C. dubliniensis for three consecutive years was positively correlated to age and erythrocyte sedimentation rate (ESR) (both p = 0.001). Conclusions: Cystic fibrosis patients who were cultured positive for C. dubliniensis, C. albicans or A. fumigatus in sputum exhibited a decline in ppFEV1 over time. The effect was most pronounced for C. dubliniensis.http://www.sciencedirect.com/science/article/pii/S1201971220303702Cystic fibrosisMoldsYeastsCandida albicansCandida dubliniensisAspergillus fumigatus |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mahasin Al Shakirchi Lena Klingspor Peter Bergman Lena Hjelte Isabelle de Monestrol |
spellingShingle |
Mahasin Al Shakirchi Lena Klingspor Peter Bergman Lena Hjelte Isabelle de Monestrol A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function International Journal of Infectious Diseases Cystic fibrosis Molds Yeasts Candida albicans Candida dubliniensis Aspergillus fumigatus |
author_facet |
Mahasin Al Shakirchi Lena Klingspor Peter Bergman Lena Hjelte Isabelle de Monestrol |
author_sort |
Mahasin Al Shakirchi |
title |
A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function |
title_short |
A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function |
title_full |
A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function |
title_fullStr |
A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function |
title_full_unstemmed |
A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function |
title_sort |
16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: candida dubliniensis was associated with a decline in lung function |
publisher |
Elsevier |
series |
International Journal of Infectious Diseases |
issn |
1201-9712 |
publishDate |
2020-07-01 |
description |
Objectives: To study the prevalence of fungal species in cystic fibrosis (CF) patients over a 16 years period. To examine the impact of Candida albicans (C. albicans), Candida dubliniensis (C. dubliniensis) and Aspergillus fumigatus (A. fumigatus) on lung function. Methods: Observational single-center cohort study (2000–2015) including 133 CF patients (ages 6–66 years). Linear mixed models with autoregressive covariance matrix were used. Results: The most common fungus was C. albicans (prevalence 62%) followed by A. fumigatus (22%) and C. dubliniensis (11%). In the initial year of detection, there was no impact of C. albicans, C. dubliniensis or A. fumigatus on lung function. However, one and two years after detection of C. dubliniensis a reduction in percent predicted forced expiratory volume in the first second (ppFEV1) was observed of 3.8% (p = 0.022) and 4.1% (p = 0.017), respectively, compared with CF patients without these findings. Furthermore, patients with positive cultures for any of these fungal species for three consecutive years exhibited a decline in lung function: C. dubliniensis, 7.6% reduction in ppFEV1 (p = 0.001); A. fumigatus, 4.9% (p = 0.007); C. albicans, 2.6% (p = 0.014). The results were adjusted for age, CFTR genotype, chronic and intermittent P. aeruginosa colonization, and numbers of intravenous antibiotic treatments per year. Persistence of C. dubliniensis for three consecutive years was positively correlated to age and erythrocyte sedimentation rate (ESR) (both p = 0.001). Conclusions: Cystic fibrosis patients who were cultured positive for C. dubliniensis, C. albicans or A. fumigatus in sputum exhibited a decline in ppFEV1 over time. The effect was most pronounced for C. dubliniensis. |
topic |
Cystic fibrosis Molds Yeasts Candida albicans Candida dubliniensis Aspergillus fumigatus |
url |
http://www.sciencedirect.com/science/article/pii/S1201971220303702 |
work_keys_str_mv |
AT mahasinalshakirchi a16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction AT lenaklingspor a16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction AT peterbergman a16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction AT lenahjelte a16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction AT isabelledemonestrol a16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction AT mahasinalshakirchi 16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction AT lenaklingspor 16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction AT peterbergman 16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction AT lenahjelte 16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction AT isabelledemonestrol 16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction |
_version_ |
1724719553503559680 |